医学
血管生成
癌症研究
心力衰竭
心脏纤维化
PI3K/AKT/mTOR通路
内皮干细胞
压力过载
内皮功能障碍
内皮
心功能曲线
间质细胞
调节器
黑色素瘤
血管内皮生长因子
血管内皮生长因子A
治疗性血管生成
细胞生物学
人口
新生血管
血管内皮生长因子B
下调和上调
纤维化
基因剔除小鼠
蛋白激酶B
离体
细胞生长
免疫学
作者
Haihuan Lin,Zhihui Yang,Chi Zhang,Lingzhi Ruan,Zemin Huang,Chenglv Hong,Haocheng Lu,Jie Lin
标识
DOI:10.1161/jaha.126.050564
摘要
Background Pressure overload‐induced heart failure involves maladaptive cardiac remodeling and inadequate angiogenesis. The limitations of VEGF (vascular endothelial growth factor)‐based therapies underscore the need to identify alternative angiogenic pathways. GPNMB (glycoprotein nonmetastatic melanoma protein B) is a macrophage‐secreted protein implicated in tissue repair, but its role in pressure overload‐induced cardiac remodeling and its potential to modulate angiogenesis remain unknown. Methods Myeloid‐specific Gpnmb knockout and control mice were subjected to transverse aortic constriction. Cardiac function, remodeling, and capillary density were assessed. Single‐cell RNA sequencing was performed to identify transcriptomic changes. In vitro, human endothelial cells were treated with recombinant GPNMB to assess proliferation, migration, and tube formation, and to dissect the underlying signaling pathways. The therapeutic potential of Gpnmb overexpression was evaluated using AAV9 vectors. Results Myeloid Gpnmb deletion exacerbated transverse aortic constriction‐induced cardiac dysfunction, hypertrophy, fibrosis, and capillary rarefaction. Single‐cell sequencing revealed a reduced capillary endothelial cell population and pathway enrichment indicative of endothelial dysfunction and metabolic reprogramming in myeloid‐specific Gpnmb knockout hearts. Mechanistically, GPNMB directly promoted endothelial cell proliferation, migration, and tube formation by activating the mTOR (mechanistic target of rapamycin) pathway in a CD44‐dependent manner, independently of VEGF signaling. Cardiac‐specific Gpnmb overexpression rescued angiogenesis, improved cardiac function, and attenuated pathological remodeling after transverse aortic constriction. Conclusions Macrophage‐derived GPNMB is a critical regulator of cardiac adaptation to pressure overload. It promotes a VEGF‐independent angiogenic program probably via the CD44/mTOR axis, as supported by in vitro mechanistic studies. GPNMB represents a promising therapeutic target for heart failure characterized by microvascular rarefaction.
科研通智能强力驱动
Strongly Powered by AbleSci AI